A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
10 2019
Historique:
received: 18 04 2019
revised: 24 06 2019
accepted: 18 07 2019
pubmed: 25 7 2019
medline: 13 8 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

By examination of the cancer genomics database, we identified a new set of mutations in core histones that frequently recur in cancer patient samples and are predicted to disrupt nucleosome stability. In support of this idea, we characterized a glutamate to lysine mutation of histone H2B at amino acid 76 (H2B-E76K), found particularly in bladder and head and neck cancers, that disrupts the interaction between H2B and H4. Although H2B-E76K forms dimers with H2A, it does not form stable histone octamers with H3 and H4

Identifiants

pubmed: 31337617
pii: 2159-8290.CD-19-0393
doi: 10.1158/2159-8290.CD-19-0393
pmc: PMC6774836
mid: NIHMS1535685
doi:

Substances chimiques

Histones 0
Nucleosomes 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1438-1451

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB014869
Pays : United States
Organisme : NIGMS NIH HHS
ID : P41 GM108569
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM115945
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA143869
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA193419
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2019 American Association for Cancer Research.

Références

Nucleic Acids Res. 2018 Nov 2;46(19):10007-10018
pubmed: 30053102
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Science. 1974 May 24;184(4139):865-8
pubmed: 4825888
Nucleic Acids Res. 2018 Sep 28;46(17):8665-8678
pubmed: 30165676
Science. 2011 Aug 26;333(6046):1157-60
pubmed: 21798893
Cell. 1980 Dec;22(3):799-805
pubmed: 7006833
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Nature. 2019 Mar;567(7749):473-478
pubmed: 30894748
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nat Struct Mol Biol. 2013 Mar;20(3):267-73
pubmed: 23463311
Science. 2013 May 17;340(6134):857-61
pubmed: 23539183
Science. 1996 Oct 25;274(5287):614-7
pubmed: 8849453
Nat Rev Mol Cell Biol. 2017 Feb;18(2):115-126
pubmed: 27924075
Cancer Lett. 2017 Jun 28;396:42-52
pubmed: 28288875
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Nature. 2011 Jan 20;469(7330):343-9
pubmed: 21248841
Comput Phys Commun. 2014 Mar;185(3):908-916
pubmed: 24944348
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
Methods Enzymol. 2004;375:23-44
pubmed: 14870657
Exp Cell Res. 1973 Mar 15;77(1):356-60
pubmed: 4570356
J Carcinog Mutagen. 2013 Jul 29;1(Suppl 5):1-12
pubmed: 25177526
Nat Genet. 2017 Feb;49(2):180-185
pubmed: 28067913
Science. 2016 May 13;352(6287):844-9
pubmed: 27174990
PLoS One. 2011;6(7):e21800
pubmed: 21789182
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2462-71
pubmed: 24889621
EMBO Rep. 2015 Nov;16(11):1439-53
pubmed: 26474902
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Mol Cell. 2015 Jun 4;58(5):886-99
pubmed: 26004229
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Nat Commun. 2016 Apr 28;7:11316
pubmed: 27121947
J Cell Biol. 2014 Jan 20;204(2):231-45
pubmed: 24446482
Biophys J. 2004 Jun;86(6):4004-14
pubmed: 15189896
J Mol Biol. 1998 Feb 13;276(1):19-42
pubmed: 9514715
Acta Neuropathol. 2012 Sep;124(3):439-47
pubmed: 22661320
Nature. 2011 May 5;473(7345):43-9
pubmed: 21441907
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nature. 2012 Jan 29;482(7384):226-31
pubmed: 22286061
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12238-12243
pubmed: 27791010
Cell. 1987 Apr 24;49(2):203-10
pubmed: 3568125
Epigenetics Chromatin. 2017 Oct 18;10(1):48
pubmed: 29047414
Methods Cell Biol. 2004;78:45-64
pubmed: 15646615
Science. 2016 Sep 30;353(6307):
pubmed: 27708074
Science. 1974 May 24;184(4139):868-71
pubmed: 4825889
Nat Genet. 2013 Dec;45(12):1479-82
pubmed: 24162739

Auteurs

Richard L Bennett (RL)

Division of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.

Aditya Bele (A)

Division of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.

Eliza C Small (EC)

Division of Hematology/Oncology, Northwestern University, Evanston, Illinois.

Christine M Will (CM)

Division of Hematology/Oncology, Northwestern University, Evanston, Illinois.

Behnam Nabet (B)

Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.

Jon A Oyer (JA)

Division of Hematology/Oncology, Northwestern University, Evanston, Illinois.

Xiaoxiao Huang (X)

Division of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida.
Department of Chemistry, Northwestern University, Evanston, Illinois.

Rajarshi P Ghosh (RP)

Department of Bioengineering, Stanford University, Stanford, California.

Adrian T Grzybowski (AT)

Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, Illinois.

Tao Yu (T)

Department of Chemistry, Tennessee Technological University, Cookeville, Tennessee.

Qiao Zhang (Q)

Department of Chemical Engineering, University of Florida, Gainesville, Florida.

Alberto Riva (A)

Bioinformatics Core, Interdisciplinary Center for Biotechnology Research, University of Florida, Gainesville, Florida.

Tanmay P Lele (TP)

Department of Chemical Engineering, University of Florida, Gainesville, Florida.

George C Schatz (GC)

Department of Chemistry, Northwestern University, Evanston, Illinois.

Neil L Kelleher (NL)

Department of Chemistry, Northwestern University, Evanston, Illinois.

Alexander J Ruthenburg (AJ)

Department of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, Illinois.

Jan Liphardt (J)

Department of Bioengineering, Stanford University, Stanford, California.

Jonathan D Licht (JD)

Division of Hematology/Oncology, University of Florida Health Cancer Center, Gainesville, Florida. jdlicht@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH